Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of $3.55 and traded as high as $3.5550. Medexus Pharmaceuticals shares last traded at $3.5550, with a volume of 3,218 shares changing hands.
Medexus Pharmaceuticals Trading Up 4.1%
The company has a fifty day moving average of $3.55 and a 200-day moving average of $3.00.
About Medexus Pharmaceuticals
Medexus Pharmaceuticals is a specialty pharmaceutical company focused on acquiring, developing and commercializing medicines for patients with underserved medical needs. Its activities span areas including hematology, oncology, rheumatology and allergy.
In the United States, its marketed products include IXINITY, a recombinant factor IX treatment for hemophilia B; Gleolan, used to help surgeons visualize certain brain tumors; and Rasuvo, a methotrexate injection for inflammatory conditions.
Featured Articles
- Five stocks we like better than Medexus Pharmaceuticals
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
